Insider Actions for Horizon Therapeutics PLC
– Purchase
– Sale
1
– Number of Transactions
Date
Name
Transaction
Value
| 01/11/2023 |
Jeffrey W. Sherman EVP and Chief Medical Officer |
3,368 | Disposition at $113.1 per share. | 380,920 |
| 01/10/2023 |
Jeffrey W. Sherman EVP and Chief Medical Officer |
3,368 | Disposition at $113.05 per share. | 380,752 |
| 01/06/2023 |
Jeffrey W. Sherman EVP and Chief Medical Officer |
5,187 | Disposition at $113.29 per share. | 587,635 |
| 01/05/2023 |
Timothy P. Walbert Chairman, President and CEO; Director |
97,461 | Derivative/Non-derivative trans. at $113.24 per share. | 11,036,483 |
| 01/05/2023 |
Michael A. DesJardin EVP, Technical Operations |
26,901 | Derivative/Non-derivative trans. at $113.24 per share. | 3,046,269 |
| 01/05/2023 |
Patrick McIlvenny Chief Accounting Officer |
4,147 | Derivative/Non-derivative trans. at $113.24 per share. | 469,606 |
| 01/05/2023 |
Timothy P. Walbert Chairman, President and CEO; Director |
219,995 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 01/05/2023 |
Michael A. DesJardin EVP, Technical Operations |
54,253 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 01/05/2023 |
Patrick McIlvenny Chief Accounting Officer |
7,973 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 01/01/2023 |
Timothy P. Walbert Chairman, President and CEO; Director |
46,365 | Derivative/Non-derivative trans. at $113.8 per share. | 5,276,337 |
| 01/01/2023 |
Jeffrey W. Sherman EVP and Chief Medical Officer |
9,717 | Derivative/Non-derivative trans. at $113.8 per share. | 1,105,794 |
| 01/01/2023 |
Michael A. DesJardin EVP, Technical Operations |
9,561 | Derivative/Non-derivative trans. at $113.8 per share. | 1,088,041 |
| 01/01/2023 |
Timothy P. Walbert Chairman, President and CEO; Director |
104,498 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 01/01/2023 |
Jeffrey W. Sherman EVP and Chief Medical Officer |
21,772 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 01/01/2023 |
Michael A. DesJardin EVP, Technical Operations |
21,772 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 12/30/2022 |
Andy Pasternak EVP, Chief Strategy Officer |
39,313 | Derivative/Non-derivative trans. at $113.8 per share. | 4,473,819 |
| 12/30/2022 |
Aaron L. Cox EVP, Chief Financial Officer |
28,758 | Derivative/Non-derivative trans. at $113.8 per share. | 3,272,660 |
| 12/30/2022 |
Elizabeth H. Z. Thompson EVP, Research & Development |
9,449 | Derivative/Non-derivative trans. at $113.8 per share. | 1,075,296 |
| 12/30/2022 |
Jeff Himawan Director |
2,230 | Gift at $0 per share. | 0 |
| 12/30/2022 |
Andy Pasternak EVP, Chief Strategy Officer |
88,733 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 12/30/2022 |
Aaron L. Cox EVP, Chief Financial Officer |
64,906 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 12/30/2022 |
Elizabeth H. Z. Thompson EVP, Research & Development |
19,055 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 12/15/2022 |
Aaron L. Cox EVP, Chief Financial Officer |
4,774 | Gift at $0 per share. | 0 |
| 12/13/2022 |
Andy Pasternak EVP, Chief Strategy Officer |
6,918 | Disposition at $112.6 per share. | 778,966 |
| 12/13/2022 |
Andy Pasternak EVP, Chief Strategy Officer |
23,251 | Disposition at $112.61 per share. | 2,618,295 |
| 12/13/2022 |
Andy Pasternak EVP, Chief Strategy Officer |
23,251 | Derivative/Non-derivative trans. at $29.52 per share. | 686,369 |
| 12/12/2022 |
Jeffrey W. Sherman EVP and Chief Medical Officer |
21,378 | Disposition at $111.45 per share. | 2,382,578 |
| 12/12/2022 |
Jeffrey W. Sherman EVP and Chief Medical Officer |
6,974 | Disposition at $111.44 per share. | 777,182 |
| 11/01/2022 |
Andy Pasternak EVP, Chief Strategy Officer |
5,503 | Derivative/Non-derivative trans. at $63.18 per share. | 347,679 |
| 11/01/2022 |
Andy Pasternak EVP, Chief Strategy Officer |
12,421 | Derivative/Non-derivative trans. at $0 per share. | 0 |
